Skip to main content

and
  1. Article

    Open Access

    Anus preservation in low rectal adenocarcinoma based on MMR/MSI status (APRAM): a study protocol for a randomised, controlled, open-label, multicentre phase III trial

    Anus preservation has been a challenge in the treatment of patients with low rectal adenocarcinoma (within 5 cm from the anal verge) because it is difficult to spare the anus with its functioning sphincter com...

    Cheng-Yi Huang, Ming-Hua Bai, **-Wen Shen, Quan-Quan Sun, Yan-Ru Feng in BMC Cancer (2024)

  2. Article

    Open Access

    Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate

    In this era of oxaliplatin-based adjuvant therapy, the optimal sequence in which chemoradiotherapy should be administered for pathological stage N2 rectal cancer is unknown. The aim of this study was to invest...

    Yan-Ru Feng, **g **, Hua Ren, **n Wang, Shu-Lian Wang, Wei-Hu Wang in BMC Cancer (2017)